Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$33.4 - $45.2 $1.02 Million - $1.38 Million
30,484 Added 103.57%
59,916 $2.12 Million
Q4 2023

Feb 01, 2024

BUY
$34.21 - $44.59 $248,090 - $323,366
7,252 Added 32.7%
29,432 $1.28 Million
Q3 2023

Nov 02, 2023

SELL
$37.8 - $45.97 $704,365 - $856,604
-18,634 Reduced 45.66%
22,180 $847,000
Q2 2023

Jul 31, 2023

BUY
$37.95 - $58.98 $1.55 Million - $2.41 Million
40,814 New
40,814 $1.68 Million
Q3 2022

Nov 03, 2022

BUY
$42.28 - $57.17 $1.1 Million - $1.48 Million
25,912 Added 253.77%
36,123 $1.53 Million
Q2 2022

Aug 08, 2022

BUY
$53.86 - $66.52 $125,493 - $154,991
2,330 Added 29.56%
10,211 $552,000
Q1 2022

May 09, 2022

SELL
$62.86 - $69.24 $219,318 - $241,578
-3,489 Reduced 30.69%
7,881 $506,000
Q4 2021

Feb 02, 2022

SELL
$62.47 - $73.25 $1.21 Million - $1.42 Million
-19,366 Reduced 63.01%
11,370 $762,000
Q3 2021

Nov 08, 2021

BUY
$64.97 - $76.19 $1.14 Million - $1.34 Million
17,582 Added 133.66%
30,736 $2.11 Million
Q2 2021

Aug 09, 2021

BUY
$66.79 - $76.63 $878,555 - $1.01 Million
13,154 New
13,154 $898,000
Q4 2020

Feb 09, 2021

SELL
$43.31 - $66.55 $1.22 Million - $1.88 Million
-28,200 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$43.33 - $51.72 $855,550 - $1.02 Million
19,745 Added 233.53%
28,200 $1.33 Million
Q2 2020

Jul 29, 2020

BUY
$41.42 - $55.57 $350,206 - $469,844
8,455 New
8,455 $397,000
Q1 2020

May 06, 2020

SELL
$36.67 - $61.04 $424,785 - $707,087
-11,584 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$55.73 - $62.49 $14,824 - $16,622
-266 Reduced 2.24%
11,584 $675,000
Q3 2019

Nov 08, 2019

BUY
$53.29 - $64.59 $631,486 - $765,391
11,850 New
11,850 $712,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.